Medical cannabis in the United States
Medical cannabis in the United States[edit]
Medical cannabis in the United States refers to the use of cannabis and its cannabinoids for medical purposes in the United States. Although cannabis remains a Schedule I drug under federal law, many states have legalized its medical use.
History[edit]
The use of cannabis for medical purposes dates back to ancient times. In the United States, the use of cannabis for medical purposes was first legalized in California in 1996 with the passage of Proposition 215. Since then, 33 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands have approved comprehensive, publicly available medical cannabis programs.
Federal law[edit]
Despite the legalization of medical cannabis in many states, it remains illegal under federal law. The Controlled Substances Act of 1970 classified cannabis as a Schedule I drug, which means it is considered to have a high potential for abuse and no accepted medical use. However, the federal government has generally not intervened with states' medical cannabis programs.
State laws[edit]
Each state that has legalized medical cannabis has its own unique set of laws and regulations. Some states allow patients to grow their own cannabis, while others require it to be purchased from licensed dispensaries. Some states have also established systems to regulate the production and distribution of medical cannabis.
Medical uses[edit]
Cannabis is used to treat a variety of medical conditions, including chronic pain, nausea and vomiting associated with chemotherapy, and spasticity from multiple sclerosis. Some studies have also suggested that cannabis may be effective in treating epilepsy and posttraumatic stress disorder.
Research[edit]
Research into the medical benefits of cannabis is ongoing. However, the classification of cannabis as a Schedule I drug has made it difficult for researchers to obtain the drug for study. Despite these challenges, a number of studies have found evidence of the medical benefits of cannabis.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
